Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

RP-HPLC Analysis for Quantitation of Candesartan Cilexetil in Solid Dosage Forms


Affiliations
1 Department of Pharmaceutical Analysis, The Erode College of Pharmacy and Research, Erode, Tamil Nadu, India
2 Department of Pharmaceutics, The Erode College of Pharmacy and Research, Erode, Tamil Nadu, India
     

   Subscribe/Renew Journal


A simple reverse phase liquid chromatographic method was developed and validated as per the ICH guidelines for the quantitative determination of candesartan cilexetil in pharmaceutical dosage forms. The mobile phase consisted of 0.02 M mono basic potassium phosphate buffer: acetonitrile: triethyl amine (40:60:0.2) and adjust pH to 6.0 with ortho phosphoric acid. The eluent was monitored at 254 nm, at a flow rate of 2 mL/min and retention time was observed at 9.153 min. The linearity was observed from 0.08071-0.24213 mg/mL with R2= 0.998. The LOD and LOQ were found to be 0.00005 mg/mL and 0.00017 mg/mL respectively. This method was also validated and can be successfully applied for routine analysis.

Keywords

Candesartan Cilexetil, RP-HPLC, Validation.
Subscription Login to verify subscription
User
Notifications
Font Size


Abstract Views: 259

PDF Views: 0




  • RP-HPLC Analysis for Quantitation of Candesartan Cilexetil in Solid Dosage Forms

Abstract Views: 259  |  PDF Views: 0

Authors

R. Revathi
Department of Pharmaceutical Analysis, The Erode College of Pharmacy and Research, Erode, Tamil Nadu, India
V. S. Saravanan
Department of Pharmaceutical Analysis, The Erode College of Pharmacy and Research, Erode, Tamil Nadu, India
T. Ethiraj
Department of Pharmaceutics, The Erode College of Pharmacy and Research, Erode, Tamil Nadu, India
Jhansi Lakshmi Marreddy
Department of Pharmaceutical Analysis, The Erode College of Pharmacy and Research, Erode, Tamil Nadu, India

Abstract


A simple reverse phase liquid chromatographic method was developed and validated as per the ICH guidelines for the quantitative determination of candesartan cilexetil in pharmaceutical dosage forms. The mobile phase consisted of 0.02 M mono basic potassium phosphate buffer: acetonitrile: triethyl amine (40:60:0.2) and adjust pH to 6.0 with ortho phosphoric acid. The eluent was monitored at 254 nm, at a flow rate of 2 mL/min and retention time was observed at 9.153 min. The linearity was observed from 0.08071-0.24213 mg/mL with R2= 0.998. The LOD and LOQ were found to be 0.00005 mg/mL and 0.00017 mg/mL respectively. This method was also validated and can be successfully applied for routine analysis.

Keywords


Candesartan Cilexetil, RP-HPLC, Validation.